Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Net Cash Flow: 2024-2025

Historic Net Cash Flow for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $13.3 million.

  • Kura Oncology's Net Cash Flow rose 210.43% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year change of. This contributed to the annual value of $187.1 million for FY2024, which is 1392.07% up from last year.
  • Per Kura Oncology's latest filing, its Net Cash Flow stood at $13.3 million for Q3 2025, which was down 56.52% from $30.7 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Net Cash Flow ranged from a high of $175.0 million in Q4 2024 and a low of -$173.2 million during Q1 2025.